Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza for Mood Resilience in Soldiers
NCT01216982Phase 2Unknown
- Sponsor
- United States Department of Defense
- Start
- Nov 2010
- Primary completion
- Feb 2011
- Countries
- 1
01
Overview
A Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in mood disorder, major depressive disorder (MDD), Combat Disorders, stress-related disorders, sponsored by United States Department of Defense. Status: unknown.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
mood disordermajor depressive disorder (MDD)Combat Disordersstress-related disorders
Beyond the preview
Go deeper on NCT01216982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216982.